Byrne; Barry J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Byrne; Barry J..The latest application filed is for "recombinant aav production in mammalian cells".

Company Profile

1.13.23

Byrne; Barry J. - Gainesville FL
Byrne; Barry J. - Gainsville FL
Byrne; Barry J. - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant Aav Production In Mammalian Cells App 20210340503 - Hwang; Kyu-Kye ; et al.	2021-11-04
Recombinant Aav Production In Mammalian Cells App 20190017033 - Hwang; Kyu-Kye ; et al.	2019-01-17
Recombinant Aav Production In Mammalian Cells App 20170362577 - Hwang; Kyu-Kye ; et al.	2017-12-21
Adeno-associated virus vectors for treatment of glycogen storage disease Grant 9,644,216 - Chou , et al. May 9, 2	2017-05-09
Adeno-associated Virus Vectors For Treatment Of Glycogen Storage Disease App 20160376608 - Chou; Janice J. ; et al.	2016-12-29
Recombinant Aav Production In Mammalian Cells App 20160024480 - Hwang; Kyu-Kye ; et al.	2016-01-28
Methods of treating anemia using recombinant adeno-associated virus virions Grant 7,829,078 - Podsakoff , et al. November 9, 2	2010-11-09
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions Grant 7,704,492 - Podsakoff , et al. April 27, 2	2010-04-27
Methods of treating anemia using recombinant adeno-associated virus virions App 20090208459 - Podsakoff; Gregory M. ; et al.	2009-08-20
rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes App 20090186002 - Flotte; Terence R. ; et al.	2009-07-23
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20080305084 - Podsakoff; Gregory M. ; et al.	2008-12-11
Gel-based Delivery Of Recombinant Adeno-associated Virus Vectors App 20080279945 - Mah; Cathryn S. ; et al.	2008-11-13
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors App 20080199442 - Podsakoff; Gregory M. ; et al.	2008-08-21
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors App 20080069803 - Podsakoff; Gregory M. ; et al.	2008-03-20
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors Grant 7,238,674 - Podsakoff , et al. July 3, 2	2007-07-03
Production of pseudotyped recombinant AAV virions App 20070015238 - Snyder; Richard O. ; et al.	2007-01-18
Production of pseudotyped recombinant AAV virions Grant 7,094,604 - Snyder , et al. August 22, 2	2006-08-22
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors App 20060099184 - Podsakoff; Gregory M. ; et al.	2006-05-11
Gel-based delivery of recombinant adeno-associated virus vectors App 20060078542 - Mah; Cathryn S. ; et al.	2006-04-13
Production of pseudotyped recombinant AAV virions App 20040209245 - Snyder, Richard O. ; et al.	2004-10-21
Methods for large-scale production of recombinant AAV vectors Grant 6,783,972 - Byrne , et al. August 31, 2	2004-08-31
Method of preparing recombinant adeno-associated virus compositions App 20040121444 - Zolotukhin, Sergei ; et al.	2004-06-24
Method of preparing recombinant adeno-associated virus compositions Grant 6,660,514 - Zolotukhin , et al. December 9, 2	2003-12-09
Treatment for pompe disease App 20030223966 - Fraites, Thomas J. JR. ; et al.	2003-12-04
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20030219415 - Podsakoff, Gregory M. ; et al.	2003-11-27
Adeno associated virus vectors for the treatment of a cardiomyopathy Grant 6,610,290 - Podsakoff , et al. August 26, 2	2003-08-26
Adeno-associated viral vectors for the treatment and prevention of diabetes App 20030095949 - Flotte, Terence R. ; et al.	2003-05-22
rAAV compositions for gene therapy App 20030082162 - Flotte, Terence R. ; et al.	2003-05-01
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions App 20020155608 - Podsakoff, Gregory M. ; et al.	2002-10-24
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors App 20020147172 - Podsakoff, Gregory M. ; et al.	2002-10-10
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease Grant 6,335,011 - Podsakoff , et al. January 1, 2	2002-01-01
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors App 20010001661 - Podsakoff, Gregory M. ; et al.	2001-05-24
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors Grant 6,211,163 - Podsakoff , et al. April 3, 2	2001-04-03
Method of preparing recombinant adeno-associated virus compositions Grant 6,146,874 - Zolotukhin , et al. November 14, 2	2000-11-14
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme Grant 5,962,313 - Podsakoff , et al. October 5, 1	1999-10-05
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors Grant 5,858,351 - Podsakoff , et al. January 12, 1	1999-01-12

Company Registrations

CAGE Code	46JU2	BYRNE, BARRY J UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
DUNS	604255716	BYRNE, BARRY J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.